Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
Status:
RECRUITING
Trial end date:
2026-04-15
Target enrollment:
Participant gender:
Summary
This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter referred to as GZR33) and estimate its potency in comparison with insulin degludec.